Clague Laura
CIK 0001388773
Chief Financial OfficerDirector
Filings
9
Latest Jun 16, 2023
Issuers covered
3
Showing
9 of 9
Page 1
Track record
6 of 6 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 6 | 67% | +0.1% | +0.4% | +7.3% | -8.1% |
| 90 days | 6 | 33% | -10.4% | -6.5% | +6.4% | -30.5% |
| 180 days | 6 | 83% | +8.6% | +9.4% | +16.7% | -1.3% |
| 365 days | 6 | 83% | +16.0% | +21.5% | +27.6% | -16.2% |
Issuers
Companies where Clague Laura has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| TVTX | Travere Therapeutics, Inc. | 4 | May 12, 2022 |
| GNSS | Genasys Inc. | 3 | Apr 27, 2022 |
| LAB | Standard Biotools Inc. | 2 | Jun 16, 2023 |
All filings
9 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|